My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Masimo Corp (MASI)

Masimo Stock Analysis & Ratings

Masimo Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Masimo stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


MASI Stock Stats

Previous Close$285.79
Bid0 x 0
Ask0 x 0
Today’s Range$283.36 - $292.5
52-Week Range$205.10 - $305.21
Average Volume234.44K
Market Cap$15.69B
P/E Ratio70.7
Earnings DateFeb 22, 2022
Ex-Dividend DateNov 23, 2012

Company Description

Masimo Corp

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Medical Devices & Instruments
Joseph E. Kiani
52 Discovery, Irvine, CA, 92618, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Masimo’s price range in the past 12 months?
Masimo lowest stock price was $205.10 and its highest was $305.21 in the past 12 months.
    What is Masimo’s market cap?
    Masimo’s market cap is $15.69B.
      What is Masimo’s price target?
      The average price target for Masimo is $323.33. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $330.00 ,the lowest forecast is $310.00. The average price target represents 13.79% Increase from the current price of $284.15.
        What do analysts say about Masimo?
        Masimo’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
          When is Masimo’s upcoming earnings report date?
          Masimo’s upcoming earnings report date is Feb 22, 2022 which is in 86 days.
            How were Masimo’s earnings last quarter?
            Masimo released its earnings results on Oct 26, 2021. The company reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.912 by $0.028.
              Is Masimo overvalued?
              According to Wall Street analysts Masimo’s price is currently Undervalued.
                Does Masimo pay dividends?
                Masimo pays a Notavailable dividend of $1 which represents an annual dividend yield of 0.35%. Masimo’s last Notavailable dividend payment was on Dec 11, 2012. Masimo’s upcoming ex-dividend date is Nov 23, 2012
                  What is Masimo’s EPS estimate?
                  Masimo’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Masimo have?
                  Masimo has 55,220,000 shares outstanding.
                    What happened to Masimo’s price movement after its last earnings report?
                    Masimo reported an EPS of $0.94 in its last earnings report, beating expectations of $0.912. Following the earnings report the stock price went up 1.366%.
                      Which hedge fund is a major shareholder of Masimo?
                      Among the largest hedge funds holding Masimo’s share is Gamco Investors, Inc. ET AL. It holds Masimo’s shares valued at 24M.

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis